Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2017-02-15 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LE MANS (72100), Sarthe
SELAS PHARMACIE XIONG : revenue, balance sheet and financial ratios
SELAS PHARMACIE XIONG is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LE MANS (72100),
this company of category PME
shows in 2019 a revenue of 1.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE XIONG (SIREN 827714072)
Indicator
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
1 344 383 €
1 400 471 €
1 157 902 €
Net income
-61 994 €
74 517 €
54 369 €
35 290 €
-26 049 €
12 810 €
-35 734 €
EBITDA
N/C
N/C
N/C
N/C
43 274 €
89 970 €
20 407 €
Net margin
N/C
N/C
N/C
N/C
-1.9%
0.9%
-3.1%
Revenue and income statement
In 2023, SELAS PHARMACIE XIONG records a net loss of 62 k€. This deficit will reduce equity on the balance sheet.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-61 994 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 2372%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 3%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
2371.633%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
2.663%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
Debt ratio
-2457.337
-3927.237
-1474.355
-7858.782
1336.352
437.392
2371.633
Financial autonomy
-2.94
-1.87
-4.763
-0.872
4.822
12.638
2.663
Repayment capacity
-26.295
35.555
-42.887
None
None
None
None
Cash flow / Revenue
-2.479%
1.398%
-1.114%
None%
None%
None%
None%
Sector positioning
Debt ratio
2371.632023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Watch
In 2023, the debt ratio of SELAS PHARMACIE XIONG (2371.63) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
2.66%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of SELAS PHARMACIE XIONG (2.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 56.94. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
113.552
103.174
79.088
103.826
101.245
98.36
56.94
Interest coverage
95.408
11.998
25.376
None
None
None
None
Sector positioning
Liquidity ratio
56.942023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Watch-7 pts over 3 years
In 2023, the liquidity ratio of SELAS PHARMACIE XIONG (56.94) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 181 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 1668 days. Excellent situation: suppliers finance 1487 days of the operating cycle (retail model).
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
181 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
1668 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELAS PHARMACIE XIONG
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
Operating WCR
126 802 €
154 500 €
113 963 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
39
36
31
0
0
0
0
Customer payment term (days)
8
7
5
128
96
341
181
Supplier payment term (days)
82
69
90
1443
1388
1472
1668
Positioning of SELAS PHARMACIE XIONG in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE XIONG with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE XIONG
What is the revenue of SELAS PHARMACIE XIONG ?
The revenue of SELAS PHARMACIE XIONG in 2019 is 1.3 M€.
Is SELAS PHARMACIE XIONG profitable?
SELAS PHARMACIE XIONG recorded a net loss in 2023.
Where is the headquarters of SELAS PHARMACIE XIONG ?
The headquarters of SELAS PHARMACIE XIONG is located in LE MANS (72100), in the department Sarthe.
Where to find the tax return of SELAS PHARMACIE XIONG ?
The tax return of SELAS PHARMACIE XIONG is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE XIONG operate?
SELAS PHARMACIE XIONG operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart